Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06896929

Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies

Comparison of Topical Permethrin 1 Day Verses 2 Day Application Versus Oral Ivermectin for Treatment of Scabies in Children Greater Than 6 Yrs of Age

Status
Not Yet Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Children Hospital and Institute of Child Health, Lahore · Academic / Other
Sex
All
Age
6 Years – 15 Years
Healthy volunteers
Not accepted

Summary

Scabies is highly contagious,pruritic infestation of skin.Various treatment modalities have been used but search for ideal scabicide is ongoing.we wnt to coduct this study to compare the outcome of permethrin verses ivermectin in children for treatment of scabies .This randomized clinical trial will be done in children hospital lahore for 12 months.Sample size of 90 cases;30 in each group will be included through non probability consecutive sampling.Then patient will be randomly divided into 3 groups.In group A patient will be given 5% permethrin topical application to whole body single application. In Group B ,patients will be given topical permethrin for twice application 24 hrs appart ,In group C patients will be given Tablet Ivermectin single dose 200microgram/kg.Then patients will be examined after 2 weeks and 4 weeks for no of lesions and pruritis and cure will be labeled.All this information will be recorded on performa .Data will be entered and analysed by using SPSS version 26.Three groups will be compared for cure by using chi-square test.P value less than and equal to 0.05 will be considered as significant.

Conditions

Interventions

TypeNameDescription
DRUGPermethrin Cream, 5%Permethrin 5% cream will be given as a single application
DRUGPermethrin Cream, 5%Permethrin Cream will be given as twice application
DRUGIvermectin 200 µg/kgGroup C will be given Tab Ivermectin

Timeline

Start date
2025-05-01
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2025-03-26
Last updated
2025-04-20

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06896929. Inclusion in this directory is not an endorsement.